Ahn-Gook Pharmaceutical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ahn-Gook Pharmaceutical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	33.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Are Dividend Investors Making A Mistake With Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?

Apr 02

Ahn-Gook Pharmaceutical (KOSDAQ:001540) Shareholders Booked A 29% Gain In The Last Year

Mar 07

Is Ahn-Gook Pharmaceutical (KOSDAQ:001540) Using Too Much Debt?

Feb 14

Do Insiders Own Lots Of Shares In Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?

Jan 19

Dividend Investors: Don't Be Too Quick To Buy Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Upcoming Dividend

Dec 24

A Look At The Fair Value Of Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)

Dec 10

Key Things To Consider Before Buying Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Dividend

Nov 18

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ahn-Gook Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A001540 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	233,676	1,290	-7,511	-1,328	N/A
9/30/2023	226,186	4,581	-10,356	-4,583	N/A
6/30/2023	224,219	7,801	3,792	9,035	N/A
3/31/2023	213,414	8,298	2,905	7,430	N/A
12/31/2022	205,389	6,875	-1,878	1,788	N/A
9/30/2022	195,740	9,471	2,331	5,745	N/A
6/30/2022	182,760	7,005	-692	3,063	N/A
3/31/2022	175,163	4,077	-1,874	3,319	N/A
12/31/2021	163,534	3,939	-3,591	1,472	N/A
9/30/2021	149,137	1,391	-26,212	-698	N/A
6/30/2021	143,734	242	-29,439	-3,761	N/A
3/31/2021	141,126	-2,505	-20,892	3,766	N/A
12/31/2020	143,364	-1,315	-13,284	11,190	N/A
9/30/2020	156,318	-1,003	6,184	10,332	N/A
6/30/2020	160,059	215	21,598	24,970	N/A
3/31/2020	158,870	3,339	14,306	17,727	N/A
12/31/2019	155,852	2,536	18,340	22,078	N/A
9/30/2019	167,392	7,416	17,787	21,312	N/A
6/30/2019	173,064	8,524	-2,031	1,395	N/A
3/31/2019	179,166	12,862	-1,696	1,748	N/A
12/31/2018	185,746	13,220	-4,154	-1,201	N/A
9/30/2018	177,663	7,111	6,974	11,493	N/A
6/30/2018	177,601	8,641	12,562	17,725	N/A
3/31/2018	179,556	8,209	10,725	16,010	N/A
12/31/2017	183,600	8,159	12,462	17,464	N/A
9/30/2017	182,032	9,839	N/A	3,862	N/A
6/30/2017	179,048	5,884	N/A	9,188	N/A
3/31/2017	176,178	2,700	N/A	13,122	N/A
12/31/2016	174,002	1,715	N/A	12,622	N/A
9/30/2016	183,923	-185	N/A	21,903	N/A
6/30/2016	188,194	3,025	N/A	20,365	N/A
3/31/2016	195,871	7,926	N/A	26,472	N/A
12/31/2015	197,736	9,364	N/A	19,106	N/A
9/30/2015	185,569	4,360	N/A	10,633	N/A
6/30/2015	181,973	3,171	N/A	9,681	N/A
3/31/2015	173,784	1,123	N/A	546	N/A
12/31/2014	167,936	-784	N/A	1,286	N/A
9/30/2014	161,703	7,562	N/A	7,837	N/A
6/30/2014	154,380	6,775	N/A	2,261	N/A
3/31/2014	152,945	4,308	N/A	290	N/A
12/31/2013	153,972	6,767	N/A	3,642	N/A
9/30/2013	154,260	166	N/A	7,677	N/A
6/30/2013	151,795	-455	N/A	7,130	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A001540's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A001540's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A001540's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A001540's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A001540's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A001540's Return on Equity is forecast to be high in 3 years time

Ahn-Gook Pharmaceutical Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₩114 (vs ₩604 in FY 2022)

Upcoming dividend of ₩220 per share at 2.7% yield

New minor risk - Profit margin trend

Upcoming dividend of ₩220 per share

No independent directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

No independent directors

Upcoming dividend of ₩220 per share

Are Dividend Investors Making A Mistake With Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?

New 90-day low: ₩12,550

Ahn-Gook Pharmaceutical (KOSDAQ:001540) Shareholders Booked A 29% Gain In The Last Year

Is Ahn-Gook Pharmaceutical (KOSDAQ:001540) Using Too Much Debt?

Do Insiders Own Lots Of Shares In Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?

New 90-day high: ₩15,250

Dividend Investors: Don't Be Too Quick To Buy Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Upcoming Dividend

A Look At The Fair Value Of Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)

Key Things To Consider Before Buying Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Dividend

New 90-day low: ₩13,250

New 90-day high - ₩16,800

New 90-day high - ₩16,650

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies